Extremity Products Market Scope
Extremity products offer simple but high performing solutions for orthopedic trauma and reconstruction. A new distal radius plating system and a dedicated wrist articulator for fracture treatment complete the already wide range of products available for upper extremities. The treatment focuses not only on the broken bone but also considers the long-term preservation of function and quality of life for the patient. The devices for fracture reduction and bone reconstruction protect and preserve natural anatomy and limb alignment, allowing patients to move naturally very early in the healing cycle, as clinically tolerated and indicated. Continuous technological innovations in the field of extremity implants and surgery, such as stemless shoulder implants, reverse shoulder implants, mobile-bearing ankles, and new implant materials with better safety are set to drive the market for extremity products.
The Extremity Products market study is segmented by Type (Upper Extremities and Lower Extremities), by Application (Hospitals, Clinics and ASCs) and major geographies with country level break-up.
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Extremity Products market throughout the predicted period.
Johnson & Johnson (United States), Smith & Nephew (United Kingdom), Stryker Corporation (United States), Zimmer Inc. (United States), DePuy (United States), Acumed (United States), Sigma Graft (United States), Xtant Medical (United States), Trimed (India), Skye Biologics (United States) and Merete Technologies (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are NovaBone (United States) and Surgical Appliance Industries (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Extremity Products market by Type, Application and Region.
On the basis of geography, the market of Extremity Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In Nov. 2020, Stryker announced that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics., and In Sept 2020, Smith & Nephew has announced the acquisition of the extremity orthopedic business of Integra LifeSciences Holdings Corporation.
In May 2019, CrossRoads® Extremity Systems announced a merger agreement with HealthpointCapital. With the agreement, HealthpointCapital will take a controlling interest in the Company, providing access to additional operating capital for continued organic growth, market expansion, and bolt-on acquisitions to support the rapid growth of the Company.
FDA promotes a regulation under section 515(b) of the act requiring premarket approval for a device, section 501(f)(1)(A) of the act applies to the device. Because of resurfacing techniques, certain joint prostheses require far less bone resection than other devices intended to repair or replace the same joint.All the above sections required to be approved before it launches in the market
Market Trend
- Increase in R&D Expenditure for Extremity Products
Market Drivers
- Growing Feet And Bone Associated Disorders
- Increasing Number of Orthopedic Surgeries
- Highly Used in Accidental Fractures
Opportunities
- Advancement In Orthopedic Division
- Growing Healthcare Expenditure in Emerging Countries
Restraints
- Stringent Government Policies
Challenges
- High-Cost Associated with the Device
- Post-surgery Complications
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Extremity Products Manufacturers, Raw Material Suppliers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase